Notice Regarding Revision of Earnings Guidance, Distribution of Surplus (Interim Dividend) and Revision of Annual Dividend Forecast

Summary of Revision to Earnings Guidance

We have upwardly revised the consolidated full-year earnings guidance for the fiscal year ending March 2027. Sales are expected to increase from 289,700 million yen to 311,100 million yen, operating income from 66,800 million yen to 72,400 million yen, ordinary income from 68,800 million yen to 72,100 million yen, and net income attributable to owners of parent from 51,500 million yen to 53,300 million yen. Net income per share is also revised upward to 399 yen 93 sen. All segments including Functional Materials, Agricultural Chemicals, Chemicals, Healthcare and Wholesale are expected to be revised upward.

Dividend Matters and Shareholder Return Policy

The interim dividend has been increased by 8 yen to 78 yen per share, and the annual dividend is revised to 220 yen for the full year (2H total). Under the mid-term management plan Vista2027 Stage II, the return policy targets a dividend payout ratio of 55% or more and a total shareholder return ratio of 75% or more. In light of this earnings revision, we are strengthening shareholder returns.